Showing results (141-150 of 351) with videos related to

Sort By:
Pageof 36
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 23, 2021
Renal safety and biochemical changes for 2 years after switching to tenofovir alafenamide from long-term other nucleotide analog treatment in patients with chronic hepatitis BTetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi, et al.
Intervirology|January 8, 2009
Lipiodol and dye at the site of ablation decreases during RFAMiharu Hirakawa, Kenji Ikeda, Yusuke Kawamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 5, 2008
Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicinYusuke Kawamura, Kenji Ikeda, Miharu Hirakawa, et al.
Journal of Medical Virology|June 14, 2018
Circulating microRNA-122 levels are important predictor of hepatitis B virus surface antigen seroclearanceNorio Akuta, Fumitaka Suzuki, Mariko Kobayashi, et al.
Hepatology (Baltimore, Md.)|December 6, 2012
Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infectionTetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi, et al.
Journal of Medical Virology|October 25, 2013
Impact of virus clearance for the development of hemorrhagic stroke in chronic hepatitis CYasuji Arase, Mariko Kobayashi, Yusuke Kawamura, et al.
Digestive Diseases and Sciences|September 9, 2017
Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular CarcinomaKenji Ikeda, Yusuke Kawamura, Masahiro Kobayashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 3, 2019
Long-term outcome of hepatocellular carcinoma occurrence, esophageal varices exacerbation, and mortality in hepatitis C virus-related liver cirrhosis after interferon-based therapyNobuhiko Ogasawara, Satoshi Saitoh, Norio Akuta, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 22, 2017
Predictors of pruritus in patients with chronic liver disease and usefulness of nalfurafine hydrochlorideNorio Akuta, Hiromitsu Kumada, Shunichiro Fujiyama, et al.
Pageof 36